221 related articles for article (PubMed ID: 16246900)
1. The cross talk between protein kinase A- and RhoA-mediated signaling in cancer cells.
Chen Y; Wang Y; Yu H; Wang F; Xu W
Exp Biol Med (Maywood); 2005 Nov; 230(10):731-41. PubMed ID: 16246900
[TBL] [Abstract][Full Text] [Related]
2. [Effect of RhoA and cAMP on morphological changes in human prostate cancer cell line PC-3].
Chen YC; Wang Y; Yu H; Xu WR
Shi Yan Sheng Wu Xue Bao; 2005 Aug; 38(4):363-7. PubMed ID: 16231705
[TBL] [Abstract][Full Text] [Related]
3. Localization and translocation of RhoA protein in the human gastric cancer cell line SGC-7901.
Tao Y; Chen YC; Li YY; Yang SQ; Xu WR
World J Gastroenterol; 2008 Feb; 14(8):1175-81. PubMed ID: 18300342
[TBL] [Abstract][Full Text] [Related]
4. AKAPs competing peptide HT31 disrupts the inhibitory effect of PKA on RhoA activity.
Wang Y; Chen Y; Chen M; Xu W
Oncol Rep; 2006 Oct; 16(4):755-61. PubMed ID: 16969490
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase A inhibits lysophosphatidic acid-induced migration of airway smooth muscle cells.
Hirakawa M; Karashima Y; Watanabe M; Kimura C; Ito Y; Oike M
J Pharmacol Exp Ther; 2007 Jun; 321(3):1102-8. PubMed ID: 17347321
[TBL] [Abstract][Full Text] [Related]
6. An extranuclear locus of cAMP-dependent protein kinase action is necessary and sufficient for promotion of spiral ganglion neuronal survival by cAMP.
Bok J; Zha XM; Cho YS; Green SH
J Neurosci; 2003 Feb; 23(3):777-87. PubMed ID: 12574406
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Hwang YS; Lee J; Zhang X; Lindholm PF
Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
[TBL] [Abstract][Full Text] [Related]
8. Type II cGMP‑dependent protein kinase inhibits RhoA activation in gastric cancer cells.
Wang Y; Chen Y; Li Y; Lan T; Qian H
Mol Med Rep; 2014 Apr; 9(4):1444-52. PubMed ID: 24549567
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin increases RhoA activity through inhibition of PKA in the human gastric cancer cell line SGC-7901.
Li Y; Chen Y; Tao Y; Wang Y; Chen Y; Xu W
Mol Med Rep; 2011; 4(1):65-9. PubMed ID: 21461565
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid stimulates PC-3 prostate cancer cell Matrigel invasion through activation of RhoA and NF-kappaB activity.
Hwang YS; Hodge JC; Sivapurapu N; Lindholm PF
Mol Carcinog; 2006 Jul; 45(7):518-29. PubMed ID: 16402387
[TBL] [Abstract][Full Text] [Related]
11. Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction.
van Nieuw Amerongen GP; Vermeer MA; van Hinsbergh VW
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):E127-33. PubMed ID: 11116077
[TBL] [Abstract][Full Text] [Related]
12. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A inhibits lysophosphatidic acid induction of serum response factor via alterations in the actin cytoskeleton.
Nguyen GH; French R; Radhakrishna H
Cell Signal; 2004 Oct; 16(10):1141-51. PubMed ID: 15240009
[TBL] [Abstract][Full Text] [Related]
14. Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA.
Yu X; Zhang Q; Zhao Y; Schwarz BJ; Stallone JN; Heaps CL; Han G
PLoS One; 2017; 12(3):e0173085. PubMed ID: 28278256
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: assembly of a multiprotein signaling complex.
Misra UK; Pizzo SV
J Cell Biochem; 2012 May; 113(5):1488-500. PubMed ID: 22173835
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer.
Kamrava M; Simpkins F; Alejandro E; Michener C; Meltzer E; Kohn EC
Oncogene; 2005 Oct; 24(47):7084-93. PubMed ID: 16044162
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase A-mediated phosphorylation of RhoA on serine 188 triggers the rapid induction of a neuroendocrine-like phenotype in prostate cancer epithelial cells.
Jones SE; Palmer TM
Cell Signal; 2012 Aug; 24(8):1504-14. PubMed ID: 22504159
[TBL] [Abstract][Full Text] [Related]
18. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the RhoA/Rho kinase system attenuates catecholamine biosynthesis in PC 12 rat pheochromocytoma cells.
Fukuda T; Takekoshi K; Nanmoku T; Ishii K; Isobe K; Kawakami Y
Biochim Biophys Acta; 2005 Oct; 1726(1):28-33. PubMed ID: 16219424
[TBL] [Abstract][Full Text] [Related]
20. Regulation of placental leptin expression by cyclic adenosine 5'-monophosphate involves cross talk between protein kinase A and mitogen-activated protein kinase signaling pathways.
Maymó JL; Pérez Pérez A; Dueñas JL; Calvo JC; Sánchez-Margalet V; Varone CL
Endocrinology; 2010 Aug; 151(8):3738-51. PubMed ID: 20484458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
